DOD
Search
Discussions
Biomedical Jobmarket
News
DOD Alert
Edit DOD
 
ACCOUNT
Login
Register
Forgotten Password?
 
 
Olanzapine-Induced Pancreatitis: A Case Report
 
Diabetes OD > Journals > JOP > 2004 > Journal Article

(Journal Article): Olanzapine-Induced Pancreatitis: A Case Report
 
Waage C, Carlsson H, Nielsen EW (Department of Anesthesiology and Department of Medicine, Nordland Hospital. Bodo, Norway, erikwn@fagmed.uit.no )
 
IN: JOP. J Pancreas (Online) 2004; 05(5):388-391

Fulltext:    HTML  PDF

ABSTRACT: CONTEXT: The antipsychotic agent clozapine has been linked to several cases of pancreatitis. The newer, but related, olanzapine was believed to have fewer side effects. CASE REPORT: A 42-year-old man in good physical condition gradually developed hypertriglyceridemia, hypercholesterolemia, elevated alanine aminotransferase, diabetes and, ultimately, acute pancreatitis after 19 months of olanzapine monotherapy. Due to multiorgan failure, he was in the intensive care unit and surgical ward for 29 days. He made a full recovery. The olanzapine was discontinued. Glucose, triglyceride and cholesterol levels normalized as did pancreas and liver function. CONCLUSIONS: We report olanzapine as the probable cause of acute pancreatitis in a patient without any known predisposing factors. Olanzapine-treated patients should be monitored with glucose, lipid, pancreatic function and liver function tests, and the olanzapine should be discontinued if the results of these tests worsen.

TYPE OF PUBLICATION: Case Report



 
Respond on this Journal Article!
Hint: Your Response should directly apply to Olanzapine-Induced Pancreatitis: A Case Report. Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate subject area. The actual subject area is 2004.